Wayra, Telefónica’s innovation initiative, and the pharmaceutical company AstraZeneca have. signed a collaboration agreement to jointly promote innovation initiatives within the healthcare sector. through the support of startups working on solutions applicable to the main challenges faced by healthcare.
Through this alliance, Wayra will provide AstraZeneca with access to its ecosystem and investor network while identifying startups. whose solutions can be applied to the key healthcare challenges to which the pharma wants to contribute.
The cCompanies will be able to test their solutions in real environments.with special focus on the areas of oncology, cardiovascular, renal and metabolic, respiratory and vaccines and immunotherapies.
For his part, AstraZeneca is stepping up its commitment to innovation to improve patients’ lives. through science and technology.
One of the main activities with which both companies are already working is the. ‘CKD Challenge’ (Chronic Kidney Disease). The initiative is aimed at promoting the development of technological solutions innovative technological solutions to speed up diagnosis and reduce the burden of chronic kidney disease (CKD). a serious pathology that affects 1 in 7 adults in Spain, 15% of the total population.
To meet this challenge, both Wayra and AstraZeneca seek to identify innovative solutions that contribute to early diagnosis of CKD. relying on the most innovative technologies.
